Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Go back to Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 27.78 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.76 | 52 Week Low | $28.25 | |||
| Day High | $27.98 | P/E | 16.84 | |||
| Day Low | $27.57 | EPS | $1.65 | |||
| Volume | 29,003,342 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.78 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.76 | 52 Week Low | $28.25 | |||
| Day High | $27.98 | P/E | 16.84 | |||
| Day Low | $27.57 | EPS | $1.65 | |||
| Volume | 29,003,342 | |||||

